- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Monoclonal Antibody Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Monoclonal Antibody Therapeutics market size is estimated to be worth US$ 117490 million in 2021 and is forecast to a readjusted size of USD 186150 million by 2028 with a CAGR of 6.8% during review period. Cancer accounting for % of the Monoclonal Antibody Therapeutics global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Humanized Antibody segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Monoclonal Antibody Therapeutics include Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, and GlaxoSmithKline, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Monoclonal Antibody Therapeutics market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Humanized Antibody
Human Mouse Chimeric Antibody
Market segment by Application, can be divided into
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Ophthalmological Diseases
Others
Market segment by players, this report covers
Bayer
F. Hoffmann-La Roche
Pfizer
Sanofi
GlaxoSmithKline
Merck
Novartis
AbbVie
Amgen
Johnson & Johnson
Bristol-Myers Squibb Company
Biogen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Monoclonal Antibody Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Monoclonal Antibody Therapeutics, with revenue, gross margin and global market share of Monoclonal Antibody Therapeutics from 2019 to 2022.
Chapter 3, the Monoclonal Antibody Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Monoclonal Antibody Therapeutics market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Monoclonal Antibody Therapeutics research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Monoclonal Antibody Therapeutics
1.2 Classification of Monoclonal Antibody Therapeutics by Type
1.2.1 Overview: Global Monoclonal Antibody Therapeutics Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Monoclonal Antibody Therapeutics Revenue Market Share by Type in 2021
1.2.3 Humanized Antibody
1.2.4 Human Mouse Chimeric Antibody
1.3 Global Monoclonal Antibody Therapeutics Market by Application
1.3.1 Overview: Global Monoclonal Antibody Therapeutics Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Infection
1.3.5 Hematological Diseases
1.3.6 Ophthalmological Diseases
1.3.7 Others
1.4 Global Monoclonal Antibody Therapeutics Market Size & Forecast
1.5 Global Monoclonal Antibody Therapeutics Market Size and Forecast by Region
1.5.1 Global Monoclonal Antibody Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Monoclonal Antibody Therapeutics Market Size by Region, (2017-2022)
1.5.3 North America Monoclonal Antibody Therapeutics Market Size and Prospect (2017-2028)
1.5.4 Europe Monoclonal Antibody Therapeutics Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Monoclonal Antibody Therapeutics Market Size and Prospect (2017-2028)
1.5.6 South America Monoclonal Antibody Therapeutics Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Monoclonal Antibody Therapeutics Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Monoclonal Antibody Therapeutics Market Drivers
1.6.2 Monoclonal Antibody Therapeutics Market Restraints
1.6.3 Monoclonal Antibody Therapeutics Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business
2.1.3 Bayer Monoclonal Antibody Therapeutics Product and Solutions
2.1.4 Bayer Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Bayer Recent Developments and Future Plans
2.2 F. Hoffmann-La Roche
2.2.1 F. Hoffmann-La Roche Details
2.2.2 F. Hoffmann-La Roche Major Business
2.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product and Solutions
2.2.4 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Monoclonal Antibody Therapeutics Product and Solutions
2.3.4 Pfizer Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Monoclonal Antibody Therapeutics Product and Solutions
2.4.4 Sanofi Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Product and Solutions
2.5.4 GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 GlaxoSmithKline Recent Developments and Future Plans
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Monoclonal Antibody Therapeutics Product and Solutions
2.6.4 Merck Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Merck Recent Developments and Future Plans
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Monoclonal Antibody Therapeutics Product and Solutions
2.7.4 Novartis Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Novartis Recent Developments and Future Plans
2.8 AbbVie
2.8.1 AbbVie Details
2.8.2 AbbVie Major Business
2.8.3 AbbVie Monoclonal Antibody Therapeutics Product and Solutions
2.8.4 AbbVie Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 AbbVie Recent Developments and Future Plans
2.9 Amgen
2.9.1 Amgen Details
2.9.2 Amgen Major Business
2.9.3 Amgen Monoclonal Antibody Therapeutics Product and Solutions
2.9.4 Amgen Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Amgen Recent Developments and Future Plans
2.10 Johnson & Johnson
2.10.1 Johnson & Johnson Details
2.10.2 Johnson & Johnson Major Business
2.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Product and Solutions
2.10.4 Johnson & Johnson Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Johnson & Johnson Recent Developments and Future Plans
2.11 Bristol-Myers Squibb Company
2.11.1 Bristol-Myers Squibb Company Details
2.11.2 Bristol-Myers Squibb Company Major Business
2.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product and Solutions
2.11.4 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Bristol-Myers Squibb Company Recent Developments and Future Plans
2.12 Biogen
2.12.1 Biogen Details
2.12.2 Biogen Major Business
2.12.3 Biogen Monoclonal Antibody Therapeutics Product and Solutions
2.12.4 Biogen Monoclonal Antibody Therapeutics Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Biogen Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Monoclonal Antibody Therapeutics Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Monoclonal Antibody Therapeutics Players Market Share in 2021
3.2.2 Top 10 Monoclonal Antibody Therapeutics Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Monoclonal Antibody Therapeutics Players Head Office, Products and Services Provided
3.4 Monoclonal Antibody Therapeutics Mergers & Acquisitions
3.5 Monoclonal Antibody Therapeutics New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Monoclonal Antibody Therapeutics Revenue and Market Share by Type (2017-2022)
4.2 Global Monoclonal Antibody Therapeutics Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2017-2022)
5.2 Global Monoclonal Antibody Therapeutics Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Monoclonal Antibody Therapeutics Revenue by Type (2017-2028)
6.2 North America Monoclonal Antibody Therapeutics Revenue by Application (2017-2028)
6.3 North America Monoclonal Antibody Therapeutics Market Size by Country
6.3.1 North America Monoclonal Antibody Therapeutics Revenue by Country (2017-2028)
6.3.2 United States Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
6.3.3 Canada Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
6.3.4 Mexico Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Monoclonal Antibody Therapeutics Revenue by Type (2017-2028)
7.2 Europe Monoclonal Antibody Therapeutics Revenue by Application (2017-2028)
7.3 Europe Monoclonal Antibody Therapeutics Market Size by Country
7.3.1 Europe Monoclonal Antibody Therapeutics Revenue by Country (2017-2028)
7.3.2 Germany Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
7.3.3 France Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
7.3.5 Russia Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
7.3.6 Italy Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Type (2017-2028)
8.2 Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Application (2017-2028)
8.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region
8.3.1 Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Region (2017-2028)
8.3.2 China Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
8.3.3 Japan Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
8.3.4 South Korea Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
8.3.5 India Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
8.3.7 Australia Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Monoclonal Antibody Therapeutics Revenue by Type (2017-2028)
9.2 South America Monoclonal Antibody Therapeutics Revenue by Application (2017-2028)
9.3 South America Monoclonal Antibody Therapeutics Market Size by Country
9.3.1 South America Monoclonal Antibody Therapeutics Revenue by Country (2017-2028)
9.3.2 Brazil Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
9.3.3 Argentina Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Monoclonal Antibody Therapeutics Revenue by Type (2017-2028)
10.2 Middle East & Africa Monoclonal Antibody Therapeutics Revenue by Application (2017-2028)
10.3 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country
10.3.1 Middle East & Africa Monoclonal Antibody Therapeutics Revenue by Country (2017-2028)
10.3.2 Turkey Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
10.3.4 UAE Monoclonal Antibody Therapeutics Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Monoclonal Antibody Therapeutics Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Monoclonal Antibody Therapeutics Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Monoclonal Antibody Therapeutics Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Monoclonal Antibody Therapeutics Revenue (USD Million) by Region (2017-2022)
Table 5. Global Monoclonal Antibody Therapeutics Revenue Market Share by Region (2023-2028)
Table 6. Bayer Corporate Information, Head Office, and Major Competitors
Table 7. Bayer Major Business
Table 8. Bayer Monoclonal Antibody Therapeutics Product and Solutions
Table 9. Bayer Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 11. F. Hoffmann-La Roche Major Business
Table 12. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Product and Solutions
Table 13. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Monoclonal Antibody Therapeutics Product and Solutions
Table 17. Pfizer Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Sanofi Corporate Information, Head Office, and Major Competitors
Table 19. Sanofi Major Business
Table 20. Sanofi Monoclonal Antibody Therapeutics Product and Solutions
Table 21. Sanofi Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 23. GlaxoSmithKline Major Business
Table 24. GlaxoSmithKline Monoclonal Antibody Therapeutics Product and Solutions
Table 25. GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Merck Corporate Information, Head Office, and Major Competitors
Table 27. Merck Major Business
Table 28. Merck Monoclonal Antibody Therapeutics Product and Solutions
Table 29. Merck Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Novartis Corporate Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Monoclonal Antibody Therapeutics Product and Solutions
Table 33. Novartis Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. AbbVie Corporate Information, Head Office, and Major Competitors
Table 35. AbbVie Major Business
Table 36. AbbVie Monoclonal Antibody Therapeutics Product and Solutions
Table 37. AbbVie Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Amgen Corporate Information, Head Office, and Major Competitors
Table 39. Amgen Major Business
Table 40. Amgen Monoclonal Antibody Therapeutics Product and Solutions
Table 41. Amgen Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 43. Johnson & Johnson Major Business
Table 44. Johnson & Johnson Monoclonal Antibody Therapeutics Product and Solutions
Table 45. Johnson & Johnson Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Bristol-Myers Squibb Company Corporate Information, Head Office, and Major Competitors
Table 47. Bristol-Myers Squibb Company Major Business
Table 48. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Product and Solutions
Table 49. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Biogen Corporate Information, Head Office, and Major Competitors
Table 51. Biogen Major Business
Table 52. Biogen Monoclonal Antibody Therapeutics Product and Solutions
Table 53. Biogen Monoclonal Antibody Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Global Monoclonal Antibody Therapeutics Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 55. Global Monoclonal Antibody Therapeutics Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 56. Breakdown of Monoclonal Antibody Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 57. Monoclonal Antibody Therapeutics Players Head Office, Products and Services Provided
Table 58. Monoclonal Antibody Therapeutics Mergers & Acquisitions in the Past Five Years
Table 59. Monoclonal Antibody Therapeutics New Entrants and Expansion Plans
Table 60. Global Monoclonal Antibody Therapeutics Revenue (USD Million) by Type (2017-2022)
Table 61. Global Monoclonal Antibody Therapeutics Revenue Share by Type (2017-2022)
Table 62. Global Monoclonal Antibody Therapeutics Revenue Forecast by Type (2023-2028)
Table 63. Global Monoclonal Antibody Therapeutics Revenue by Application (2017-2022)
Table 64. Global Monoclonal Antibody Therapeutics Revenue Forecast by Application (2023-2028)
Table 65. North America Monoclonal Antibody Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 66. North America Monoclonal Antibody Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 67. North America Monoclonal Antibody Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 68. North America Monoclonal Antibody Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 69. North America Monoclonal Antibody Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 70. North America Monoclonal Antibody Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 71. Europe Monoclonal Antibody Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 72. Europe Monoclonal Antibody Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 73. Europe Monoclonal Antibody Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 74. Europe Monoclonal Antibody Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 75. Europe Monoclonal Antibody Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 76. Europe Monoclonal Antibody Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 77. Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 78. Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 79. Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 80. Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 81. Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Region (2017-2022) & (USD Million)
Table 82. Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Region (2023-2028) & (USD Million)
Table 83. South America Monoclonal Antibody Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 84. South America Monoclonal Antibody Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 85. South America Monoclonal Antibody Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 86. South America Monoclonal Antibody Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 87. South America Monoclonal Antibody Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 88. South America Monoclonal Antibody Therapeutics Revenue by Country (2023-2028) & (USD Million)
Table 89. Middle East & Africa Monoclonal Antibody Therapeutics Revenue by Type (2017-2022) & (USD Million)
Table 90. Middle East & Africa Monoclonal Antibody Therapeutics Revenue by Type (2023-2028) & (USD Million)
Table 91. Middle East & Africa Monoclonal Antibody Therapeutics Revenue by Application (2017-2022) & (USD Million)
Table 92. Middle East & Africa Monoclonal Antibody Therapeutics Revenue by Application (2023-2028) & (USD Million)
Table 93. Middle East & Africa Monoclonal Antibody Therapeutics Revenue by Country (2017-2022) & (USD Million)
Table 94. Middle East & Africa Monoclonal Antibody Therapeutics Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Monoclonal Antibody Therapeutics Picture
Figure 2. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type in 2021
Figure 3. Humanized Antibody
Figure 4. Human Mouse Chimeric Antibody
Figure 5. Monoclonal Antibody Therapeutics Revenue Market Share by Application in 2021
Figure 6. Cancer Picture
Figure 7. Autoimmune Diseases Picture
Figure 8. Infection Picture
Figure 9. Hematological Diseases Picture
Figure 10. Ophthalmological Diseases Picture
Figure 11. Others Picture
Figure 12. Global Monoclonal Antibody Therapeutics Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 13. Global Monoclonal Antibody Therapeutics Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Monoclonal Antibody Therapeutics Revenue Market Share by Region (2017-2028)
Figure 15. Global Monoclonal Antibody Therapeutics Revenue Market Share by Region in 2021
Figure 16. North America Monoclonal Antibody Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Europe Monoclonal Antibody Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Asia-Pacific Monoclonal Antibody Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. South America Monoclonal Antibody Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Middle East and Africa Monoclonal Antibody Therapeutics Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Monoclonal Antibody Therapeutics Market Drivers
Figure 22. Monoclonal Antibody Therapeutics Market Restraints
Figure 23. Monoclonal Antibody Therapeutics Market Trends
Figure 24. Bayer Recent Developments and Future Plans
Figure 25. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 26. Pfizer Recent Developments and Future Plans
Figure 27. Sanofi Recent Developments and Future Plans
Figure 28. GlaxoSmithKline Recent Developments and Future Plans
Figure 29. Merck Recent Developments and Future Plans
Figure 30. Novartis Recent Developments and Future Plans
Figure 31. AbbVie Recent Developments and Future Plans
Figure 32. Amgen Recent Developments and Future Plans
Figure 33. Johnson & Johnson Recent Developments and Future Plans
Figure 34. Bristol-Myers Squibb Company Recent Developments and Future Plans
Figure 35. Biogen Recent Developments and Future Plans
Figure 36. Global Monoclonal Antibody Therapeutics Revenue Share by Players in 2021
Figure 37. Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Monoclonal Antibody Therapeutics Revenue Market Share in 2021
Figure 39. Global Top 10 Players Monoclonal Antibody Therapeutics Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Monoclonal Antibody Therapeutics Revenue Share by Type in 2021
Figure 42. Global Monoclonal Antibody Therapeutics Market Share Forecast by Type (2023-2028)
Figure 43. Global Monoclonal Antibody Therapeutics Revenue Share by Application in 2021
Figure 44. Global Monoclonal Antibody Therapeutics Market Share Forecast by Application (2023-2028)
Figure 45. North America Monoclonal Antibody Therapeutics Sales Market Share by Type (2017-2028)
Figure 46. North America Monoclonal Antibody Therapeutics Sales Market Share by Application (2017-2028)
Figure 47. North America Monoclonal Antibody Therapeutics Revenue Market Share by Country (2017-2028)
Figure 48. United States Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Monoclonal Antibody Therapeutics Sales Market Share by Type (2017-2028)
Figure 52. Europe Monoclonal Antibody Therapeutics Sales Market Share by Application (2017-2028)
Figure 53. Europe Monoclonal Antibody Therapeutics Revenue Market Share by Country (2017-2028)
Figure 54. Germany Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Monoclonal Antibody Therapeutics Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Monoclonal Antibody Therapeutics Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Monoclonal Antibody Therapeutics Revenue Market Share by Region (2017-2028)
Figure 62. China Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Monoclonal Antibody Therapeutics Sales Market Share by Type (2017-2028)
Figure 69. South America Monoclonal Antibody Therapeutics Sales Market Share by Application (2017-2028)
Figure 70. South America Monoclonal Antibody Therapeutics Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Monoclonal Antibody Therapeutics Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Monoclonal Antibody Therapeutics Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Monoclonal Antibody Therapeutics Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
